349P - Polo-like kinase 1 inhibitor onvansertib synergizes with paclitaxel in breast cancer carrying p53 mutation
| Autor: | Giordano, A., Liu, Y., Kappler, C., Park, Y., Yeh, E., Erlander, M., Ethier, S. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v125-v126 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|